IM-MS 和 ECD-MS/MS 提供了关于通过和小分子自我组装的粉样蛋白调节的见解
Hash Brown Taha1,2, Esha Chawla1,3, Gal Bitan1,4,5
1Department of Neurology, University of California Los Angeles, California 90095, United States.
Journal of the American Society for Mass Spectrometry
|August 22, 2023
概括
在神经退行性疾病中研究有毒蛋白质寡合体具有挑战性. 像IM-MS和ECD-MS/MS这样的先进质谱技术为分析这些寡合物及其与潜在治疗药物的相互作用提供了强大的方法.
科学领域:
- 生物化学 生物化学
- 神经科学是一个神经科学.
- 分析化学 分析化学
背景情况:
- 神经退行性蛋白质病症涉及错误折叠的蛋白质聚合物,导致神经元死亡.
- 转移稳定的寡合物被认为是主要的神经毒素,但研究它们很困难.
- 目前的疾病修饰疗法是有限的,尽管进行了广泛的研究.
研究的目的:
- 批判性地分析使用离子流动性光谱-质谱法 (IM-MS) 和电子捕获解离并联质谱法 (ECD-MS/MS) 来研究神经退行性蛋白质病变.
- 为了研究粉蛋白质蛋白质的寡合化和构成.
- 评估这些蛋白与潜在治疗化合物的相互作用.
主要方法:
- 利用离子流动性光谱-质谱法 (IM-MS) 来分析蛋白质的寡合化和构造.
- 采用电子捕获解离双重质谱法 (ECD-MS/MS) 来阐明连接体结合位点.
- 研究了与粉样β蛋白 (Aβ42) 的C端片段和分子笔的相互作用.
主要成果:
- 证明IM-MS在描述异常蛋白质寡合体的组成和构造方面的实用性.
- 展示了ECD-MS/MS在蛋白质上确定连接体结合位点方面的能力.
- 提供了关于氨基原蛋白与新型治疗剂之间的相互作用机制的见解.
结论:
- IM-MS和ECD-MS/MS是研究神经退行性疾病中的转移性寡合体的强大工具.
- 这些质谱方法可以促进开发有效的疾病修饰药物.
- 这些方法广泛适用于未来对蛋白质病变和药物发现的研究.
相关概念视频
Peptide Identification Using Tandem Mass Spectrometry
6.5K
Tandem mass spectrometry, also known as MS/MS or MS2, is an analytical technique that employs two mass analyzers. Essentially it is a series of mass spectrometers that helps isolate a particular biomolecule and then helps study its chemical properties.
This technique helps gather information regarding the protein from which the peptide was obtained and to study the peptides’ amino acid sequence. Identifying peptides from a complex mixture is an important component of the growing field of...
This technique helps gather information regarding the protein from which the peptide was obtained and to study the peptides’ amino acid sequence. Identifying peptides from a complex mixture is an important component of the growing field of...
6.5K
Amyloid Fibrils
9.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.6K


